Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Medicare Part B

CMS Cancels Medicare Part B Demonstration Project

From the College  |  December 16, 2016

When the controversial Medicare Part B Drug Payment Model final rule was not released by the Centers for Medicare & Medicaid Services (CMS) as expected before Nov. 21, it signaled an increasing likelihood of defeat for the proposed rule—a signal proved true on Dec. 15. A spokesperson for the CMS said, “After considering comments, CMS…

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Congressional outreachMedicare Part B Drug Payment Model final rulepatient advocacy

The Fight Against the Medicare Part B Demonstration Project

Richard Quinn  |  October 28, 2016

The ACR and 315 other organizations have publicly said savings would not be achieved by the demonstration project and that it will reduce access to care for patients…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AdvocacyCenters for Medicare & Medicaid Services (CMS)CongressMedicareMedicare Part BMedicare ReimbursementReimbursement

The ACR Continues Fight to Block Medicare Part B Demo Project: Rule Expected in Fall 2016

Kathy Holliman  |  August 4, 2016

The ACR will seek Congressional action if the Medicare Part B demonstration project proposed by the Centers for Medicare & Medicaid Services (CMS) is not significantly altered by the agency. Today, Medicare Part B generally pays physicians and hospital outpatient departments the average sales price of a drug, plus a 6% add-on, minus reductions required…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)Legislative Action CenterMedicare Part B

ACR Hill Day Participants Urge Congress to Reform Medicare Reimbursement

From the College  |  May 18, 2024

On May 6–7, nearly 100 rheumatologists and rheumatology professionals converged in Washington, D.C., for the ACR’s annual Advocacy Leadership Conference and 137 meetings on Capitol Hill. You can help extend the efforts of these advocates and amplify their impact by contacting your lawmakers via the Legislative Action Center.

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Advocacy Leadership ConferenceMedicare Reimbursement

Congressional Action Partially Addresses Medicare Cuts

From the College  |  March 7, 2024

The newest funding package reduces the latest cut to Medicare reimbursement from 3.4% to 1.68%. Although rheumatologists are faring better under Medicare in 2024, broader reforms remain the ACR’s highest priority regarding Medicare payments to physicians.

Filed under:Billing/CodingLegislation & Advocacy Tagged with:ACR advocacyMedicare Reimbursement

Off-Label Coverage of Mycophenolate for Scleroderma under Medicare Part D

From the College  |  January 6, 2020

Based on a request by the ACR Insurance Subcommittee, off-label use of mycophenolate for scleroderma has been added to a Medicare-approved compendium.

Filed under:InsurancePractice SupportSystemic Sclerosis Tagged with:ACR Insurance Subcommittee (ISC)Medicare Part DMycophenolateoff-label useScleroderma

Medicare Participation—Do Physicians Have Options?

From the College  |  April 26, 2018

Physicians have three contractual options when it comes to the Medicare program: participating, non-participating and opting out. Providers should keep the old saying “look before you leap” at the forefront when considering opting in or out of the Medicare program. Since 2001, physician costs have been on the rise, with only mini­mal increases in reimbursements,…

Filed under:From the CollegePractice Support Tagged with:Medicare

Deadline Approaches to Participate in Medicare EHR Incentive Program, aka Meaningful Use

Staff  |  April 2, 2014

2014 marks final year to reap financial benefits for adopting, implementing electronic health record system in physician practice

Filed under:EMRsFrom the CollegeTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)electronic health recordMedicarerheumatologistTechnology

Medicare Participation Numbers Don’t Tell the Whole Story

Richard Quinn  |  October 16, 2013

Although HHS reports no significant changes in Medicare participation for office-based physicians, the numbers may be misleading.  (posted Oct. 16, 2013)

Filed under:Billing/CodingPractice SupportWorkforce Tagged with:Access to careMedicarePatients

Medicare Switch to ASP Pricing Reduces Part B Spending

Staff  |  April 1, 2007

The Medicare Payment Advisory Commission (MedPAC) reported to Congress in January that Medicare’s switch to a payment method known as ASP, or Average Sale Price, has reduced spending on drugs in the Medicare Part B program. This system reflects actual market spending, rather than wholesale prices.

Filed under:Billing/CodingFrom the CollegeLegislation & AdvocacyPractice Support Tagged with:BillingCongressMedicareMedPacPractice ManagementReimbursement

  • 1
  • 2
  • 3
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences